PATENT CLAIM ANALYSIS

Application Number: 16226796
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "007700"]

Abstract:
A method of promoting wound healing or connective tissue reconstruction and a method of treating ischemia in a subject in need thereof in a subject in need thereof are disclosed. The methods comprising topically administering to the subject about 10-30 μg per cm 2  wound tissue of Erythropoietin and about 100-300 μg per cm 2  wound tissue of Fibronectin, thereby promoting wound healing or connective tissue reconstruction or treating ischemia in the subject. Unit dosage forms, pharmaceutical compositions, cosmetic compositions and formulations comprising Erythropoietin and/or Fibronectin are also disclosed.

Claim (Index 1):
A method of promoting wound healing or connective tissue reconstruction in a subject in need thereof, the method comprising topically administering to the subject about 10-30 \u03bcg per cm 2  tissue of Erythropoietin and about 100-300 \u03bcg per cm 2  tissue of Fibronectin, thereby promoting wound healing or connective tissue reconstruction in the subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.97917
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12810711', '12556402', '12741645', '15131198', '12437100']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7137445343221003
- 35 USC 102 Novelty (BERT): 0.5076894719688938
- Combined Prediction Score: 0.6931390280867796
- Mean Citation Score: 220.41108
- Max Citation Score: 223.97101
- Similarity Product: 145.86483255054952

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test